Home News General GALVmed’s 2014/15 Year in Review

(31st August 2015) As we ended the financial year 2014/15, we take stock of our progress towards the delivery of livestock vaccines and other health products to poor people in Africa and South Asia. This Year in Review documents some of the key momentums over the past year as well as highlights of activities undertaken by our key departments.

In terms of major impact, there has been remarkable progress in the delivery of an effective vaccine against Newcastle disease, a highly contagious disease of poultry which devastates village flocks in Africa and South Asia. This benefits women and children most.  A new market initiative with an Indian vaccine manufacturer will see millions of village poultry producing households being reached by 2017.  GALVmed has also successfully facilitated technology transfer to the African Union Centre for Ticks & Tick-borne Diseases (AU-CTTBD) for the production of an effective vaccine against East Coast fever (ECF) a tick-borne disease which kills a cow every 30 seconds and impacts 12 African countries.  Over 1.2 million doses of the ECF vaccine have already been produced by CTTBD.

There has also been significant progress on our other projects including Tryps phase 2 project, Rift valley project, the Porcine Cysticercosis project and the BEN-1 project which is looking at ways of controlling the Contagious Bovine Pleuropneumonia (CBPP).

Download our 2014/15 Year in Review